Seeking men and women with multiple sclerosis (MS) that hasn't responded to previous treatment for a study of an experimental drug.
Participants in this study will be assigned to one of three doses of the experimental drug. For those who are infused with the experimental drug there will be follow-up safety visits every 3 months for a year.
What we're hoping for
We are studying whether an experimental drug infused at one of three different dose strengths is safe and effective for multiple sclerosis (MS) that has not responded to previous treatment.
ClinicalTrials.gov Identifier: NCT04956744